Delegate Fees - Rs 8,999 + Taxes (All Bulk Drug Manufacturing Companies)
Vendor Delegate Fees - Rs 14,999 + Taxes (All Solution Providers/ CRO's, CDMO's / Consultants)
India’s role as the "Pharmacy of the World" is closely tied to its robust bulk drug (API) manufacturing sector. With the Government of India’s focus on API self-reliance through schemes like the PLI and Bulk Drug Parks, the landscape is rapidly evolving. However, to truly achieve global leadership, there’s a need to address key areas like process innovation, supply chain resilience, quality standards, sustainability, and regulatory harmonization.
The Pharma Bulk Drug Manufacturing Summit 2025 aims to bring together top industry leaders, technocrats, regulatory authorities, and innovators to share insights, explore challenges, and unlock new opportunities for sustainable and globally competitive API manufacturing.
Vice president & Head of Quality
Centaur Pharmaceuticals Pvt. Ltd.
Senior General Manager, Corporate Quality Assurance, Themis Medicare Limited
President – Operations, Site Head-Manufacturing Excellence.
ICHOR BIOLOGICS PVT. LTD
Vice President & Head Drug Product Manufacturing, Biological E Limited, Hyderabad
President & Chief Technology Officer
Jodas Expoim Pvt. Ltd.
Head, API-Research & Development
Shilpa Pharma Ltd
Chief Technology Officer - Biotechnology,
Biophore India Pharmaceuticals Pvt. Ltd
President & CTO
SCL Lifesciences Ltd.
Formerly Saurav chemicals Ltd
General Manager SCM
Chemveda Lifescience Pvt Ltd
Head of Regulatory Affairs
Neuland Laboratories
Vice-President (Operations)
Srikem Laboratories Private Limited
Vice President- API R&D, Apitoria Pharma (A 100% subsidiary of Aurobindo Pharma Ltd.)
Ø Driving Self-Reliance in API Manufacturing: Policy, Potential & Progress
Ø Reducing dependence on Chinese imports
Ø Bulk Drug Parks & PLI Scheme: Updates & Opportunities
Ø Infrastructure & logistics as enablers
Ø Flow chemistry, enzymatic synthesis
Ø Continuous vs batch processing
Ø Energy and cost efficiencies
Ø Tackling USFDA/EDQM audit challenges
Ø Building data integrity and QA culture
Ø Role of digitization in regulatory compliance
Ø Continuous Manufacturing vs. Batch: What’s the Future?
Ø Adopting Process Intensification and PAT (Process Analytical Technology)
Ø Cost Optimization Without Compromising Quality
Ø Green Chemistry Practices in Bulk Drug Manufacturing
Ø Effluent Treatment & Zero Liquid Discharge: Regulatory Outlook
Ø How ESG is Impacting CDMO Partnerships and Licensing
Ø Meeting USFDA, EU-GMP, and WHO-GMP Requirements
Ø Addressing Regulatory Gaps in Exporting APIs
Ø Audit Readiness for Global Markets
Ø Digital Twins, IoT, and Automation for Plant Optimization
Ø Equipment Innovation for Scale and Energy Efficiency
Ø Smart Plant Equipment & Digital Solutions for APIs
Ø Global positioning & export competitiveness
Ø Technology partnerships & talent building
Ø Integrating ESG goals into manufacturing
BlueTech Media LLP
Office no - 203, 2nd floor, Aditya Heritage, besides Rustomjee Elanza, Malad west, 400064
Copyright © 2025 BlueTech Media LLP - All Rights Reserved.
Designed by Whyte Wings Media
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.